PET Detection of CCR2 in Human Atherosclerosis

Description

: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis

Conditions

Carotid Atherosclerosis

Study Overview

Study Details

Study overview

: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis

PET Detection of CCR2 in Human Atherosclerosis

PET Detection of CCR2 in Human Atherosclerosis

Condition
Carotid Atherosclerosis
Intervention / Treatment

-

Contacts and Locations

Saint Louis

Washington University CCIR, Saint Louis, Missouri, United States, 63110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 89 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Washington University School of Medicine,

    Study Record Dates

    2024-09-01